ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost Cancer-Killing power
Disease control OngoingThis study tested adding a drug called vorinostat to standard chemotherapy (R-CHOP) for people newly diagnosed with advanced diffuse large B-cell lymphoma. The goal was to see if the combination is safe, find the right dose, and check if it helps patients live longer without thei…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Scientists test new Two-Pronged attack on tough cancers
Disease control OngoingThis early-stage study is testing a new combination of drugs for people with advanced solid tumors or non-Hodgkin lymphoma that has spread. The main goal is to find the safest and most effective dose by combining an experimental drug called veliparib with standard chemotherapy dr…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for kids with tough cancers: treatment guided by tumor genetics
Disease control OngoingThis study is testing a personalized approach for children and young adults with advanced cancers that have come back or stopped responding to standard treatments. Doctors first test the genetic makeup of a patient's tumor to look for specific changes. If a matching change is fou…
Matched conditions: ANN ARBOR STAGE IV NON-HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC